Literature DB >> 22476042

Immunoglobulin A deficiency in celiac disease.

Marisa A Chow1, Benjamin Lebwohl, Norelle Rizkalla Reilly, Peter H R Green.   

Abstract

GOALS: To determine the prevalence and significance of immunoglobulin A (IgA) deficiency and partial deficiency in patients with celiac disease (CD).
BACKGROUND: Selective IgA deficiency is a common primary immunoglobulin deficiency and has a higher prevalence in patients with CD. The prevalence and significance of IgA deficiency and partial deficiency in patients with CD in the United States has not previously been examined. STUDY: A retrospective, cohort study of 1498 adults and 317 children seen in a University Medical Center was conducted.
RESULTS: There were 26 patients (22 adults, 4 children) with CD who were IgA deficient and 11 (9 adults, 2 children) with CD who were partially IgA deficient. The prevalence of IgA deficiency/partial deficiency was similar among adults and children (2.1% and 1.9%, respectively, P=0.99). Among adults, concomitant autoimmune disease was present in 29% of IgA-deficient/partially deficient patients versus 12% of CD patients with normal IgA levels (P=0.0081). All 4 IgA-deficient patients who had persistently positive IgG celiac serologies while adherent to a gluten-free diet and were rebiopsied had a normal repeat biopsy. Both positive tissue transglutaminase IgG and antigliadin IgG were found in these patients.
CONCLUSIONS: Selective IgA deficiency/partial deficiency is present in 2% of CD patients at this referral center and is equally prevalent among adults and children. IgA-deficient/partially deficient adults had a higher prevalence of concomitant autoimmune disease than those without IgA deficiency. In patients who are IgA deficient, IgG serologies may be persistently elevated despite histologic recovery.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22476042     DOI: 10.1097/MCG.0b013e31824b2277

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  25 in total

1.  Implementation of National Institute for Health and Care Excellence (NICE) guidance to measure immunoglobulin A with all coeliac screens: can an affordable solution be devised?

Authors:  D J Mac Lochlainn; R Hira-Kazal; H Varney; J Maher
Journal:  Clin Exp Immunol       Date:  2017-05-19       Impact factor: 4.330

Review 2.  Gastrointestinal Manifestations and Complications of Primary Immunodeficiency Disorders.

Authors:  Shradha Agarwal; Charlotte Cunningham-Rundles
Journal:  Immunol Allergy Clin North Am       Date:  2019-02       Impact factor: 3.479

Review 3.  Serum markers in the clinical management of celiac disease.

Authors:  Marlou Adriaanse; Daniel A Leffler
Journal:  Dig Dis       Date:  2015-04-22       Impact factor: 2.404

4.  Identification of Pediatric Patients With Celiac Disease Based on Serology and a Classification and Regression Tree Analysis.

Authors:  Anna Ermarth; Matthew Bryce; Stephanie Woodward; Gregory Stoddard; Linda Book; M Kyle Jensen
Journal:  Clin Gastroenterol Hepatol       Date:  2016-11-12       Impact factor: 11.382

5.  Screening for celiac disease, by endomysial antibodies, in patients with unexplained articular manifestations.

Authors:  Mariam Ghozzi; Wahiba Sakly; Amani Mankaï; Elyes Bouajina; Fethi Bahri; Rafiaa Nouira; Chedia Kechrid; Ibtissem Ghedira
Journal:  Rheumatol Int       Date:  2013-12-01       Impact factor: 2.631

6.  All that glitters is not always gold.

Authors:  E Harrison; S Hayes; L Howell; S Lal
Journal:  BMJ Case Rep       Date:  2014-02-10

7.  Immunoglobulin A deficiency in celiac disease in the United States.

Authors:  Kumar Pallav; Hua Xu; Daniel A Leffler; Toufic Kabbani; Ciaran P Kelly
Journal:  J Gastroenterol Hepatol       Date:  2016-01       Impact factor: 4.029

Review 8.  Diagnosis and treatment of gastrointestinal disorders in patients with primary immunodeficiency.

Authors:  Shradha Agarwal; Lloyd Mayer
Journal:  Clin Gastroenterol Hepatol       Date:  2013-03-13       Impact factor: 11.382

Review 9.  Coeliac disease: to biopsy or not?

Authors:  Norelle R Reilly; Steffen Husby; David S Sanders; Peter H R Green
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-10-11       Impact factor: 46.802

10.  Serum autoantibodies directed against transglutaminase-2 have a low avidity compared with alloantibodies against gliadin in coeliac disease.

Authors:  K A Gelderman; A C A D Drop; L A Trouw; H J Bontkes; G Bouma; I M W van Hoogstraten; B M E von Blomberg
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.